Hiroto Kitahara to Hyperhidrosis
This is a "connection" page, showing publications Hiroto Kitahara has written about Hyperhidrosis.
Connection Strength
0.397
-
A phase III, 52-week, open-label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis. J Dermatol. 2021 Aug; 48(8):1149-1161.
Score: 0.201
-
A phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group study of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis. J Dermatol. 2021 Mar; 48(3):279-288.
Score: 0.196